Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Sulphate Antifibrotic Effect in Chronic HCV
NCT05465434Phase 3Completed
- Sponsor
- Tanta University
- Start
- Aug 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of zinc in Liver Fibrosis (LF) (2 arms), sponsored by Tanta University. Primary endpoints: Abdominal Ultrasonography at 3 months, Serum fibronectin level at 3 months and 4 more. Started Aug 2022; status: completed.
02
Drugs
zinc
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT05465434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05465434.